trending Market Intelligence /marketintelligence/en/news-insights/trending/bW90VTskgX08eZkkgda5Yw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Kubota Pharmaceutical to terminate SEC filing obligations

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Kubota Pharmaceutical to terminate SEC filing obligations

Kubota Pharmaceutical Holdings Co., Ltd. plans to terminate its reporting obligations with the U.S. Securities and Exchange Commission.

The Tokyo-based clinical stage ophthalmology company plans to file a Form 15F with the SEC and the obligations will be suspended 90 days after that.

The administrative burden and costs associated with being a U.S. reporting company outweigh the benefits, the company said a news release.

Kubota will continue to its filings with Japanese securities regulators and its common shares will continue to trade on the Tokyo Stock Exchange.